BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15853681)

  • 41. The role of Nogo-A in neuroregeneration: a review.
    Wang T; Xiong JQ; Ren XB; Sun W
    Brain Res Bull; 2012 Apr; 87(6):499-503. PubMed ID: 22414960
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Actions of neurotrophic factors and their signaling pathways in neuronal survival and axonal regeneration.
    Cui Q
    Mol Neurobiol; 2006 Apr; 33(2):155-79. PubMed ID: 16603794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myelin-associated glycoprotein-mediated signaling in central nervous system pathophysiology.
    Chen Y; Aulia S; Tang BL
    Mol Neurobiol; 2006 Oct; 34(2):81-91. PubMed ID: 17220531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myelin-associated glycoprotein reduces axonal branching and enhances functional recovery after sciatic nerve transection in rats.
    Tomita K; Kubo T; Matsuda K; Yano K; Tohyama M; Hosokawa K
    Glia; 2007 Nov; 55(14):1498-507. PubMed ID: 17705198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myelin from MAG-deficient mice is a strong inhibitor of neurite outgrowth.
    Ng WP; Cartel N; Li C; Roder J; Lozano A
    Neuroreport; 1996 Mar; 7(4):861-4. PubMed ID: 8724661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Laminin overrides the inhibitory effects of peripheral nervous system and central nervous system myelin-derived inhibitors of neurite growth.
    David S; Braun PE; Jackson DL; Kottis V; McKerracher L
    J Neurosci Res; 1995 Nov; 42(4):594-602. PubMed ID: 8568945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
    Kim JE; Liu BP; Park JH; Strittmatter SM
    Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myelin-associated glycoprotein inhibits neurite/axon growth and causes growth cone collapse.
    Li M; Shibata A; Li C; Braun PE; McKerracher L; Roder J; Kater SB; David S
    J Neurosci Res; 1996 Nov; 46(4):404-14. PubMed ID: 8950700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Simvastatin promotes neurite outgrowth in the presence of inhibitory molecules found in central nervous system injury.
    Holmberg E; Nordstrom T; Gross M; Kluge B; Zhang SX; Doolen S
    J Neurotrauma; 2006 Sep; 23(9):1366-78. PubMed ID: 16958588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury.
    Pot C; Simonen M; Weinmann O; Schnell L; Christ F; Stoeckle S; Berger P; Rülicke T; Suter U; Schwab ME
    J Cell Biol; 2002 Oct; 159(1):29-35. PubMed ID: 12379801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bone marrow stromal cells stimulate neurite outgrowth over neural proteoglycans (CSPG), myelin associated glycoprotein and Nogo-A.
    Wright KT; El Masri W; Osman A; Roberts S; Chamberlain G; Ashton BA; Johnson WE
    Biochem Biophys Res Commun; 2007 Mar; 354(2):559-66. PubMed ID: 17234155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Off-target effects of epidermal growth factor receptor antagonists mediate retinal ganglion cell disinhibited axon growth.
    Douglas MR; Morrison KC; Jacques SJ; Leadbeater WE; Gonzalez AM; Berry M; Logan A; Ahmed Z
    Brain; 2009 Nov; 132(Pt 11):3102-21. PubMed ID: 19783665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exercise decreases myelin-associated glycoprotein expression in the spinal cord and positively modulates neuronal growth.
    Ghiani CA; Ying Z; de Vellis J; Gomez-Pinilla F
    Glia; 2007 Jul; 55(9):966-75. PubMed ID: 17497667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Involvement of the Myelin-Associated Inhibitors and Their Receptors in CNS Plasticity and Injury.
    Boghdadi AG; Teo L; Bourne JA
    Mol Neurobiol; 2018 Mar; 55(3):1831-1846. PubMed ID: 28229330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CNS axon regeneration inhibitors stimulate an immediate early gene response via MAP kinase-SRF signaling.
    Stern S; Knöll B
    Mol Brain; 2014 Nov; 7():86. PubMed ID: 25406759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Defeating inhibition of regeneration by scar and myelin components.
    Fawcett JW; Schwab ME; Montani L; Brazda N; Müller HW
    Handb Clin Neurol; 2012; 109():503-22. PubMed ID: 23098733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant DNA vaccine encoding multiple domains related to inhibition of neurite outgrowth: a potential strategy for axonal regeneration.
    Xu G; Nie DY; Chen JT; Wang CY; Yu FG; Sun L; Luo XG; Ahmed S; David S; Xiao ZC
    J Neurochem; 2004 Nov; 91(4):1018-23. PubMed ID: 15525355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [FGF-2-treatment improves locomotor function via axonal regeneration in the transected rat spinal cord].
    Furukawa S; Furukawa Y
    Brain Nerve; 2007 Dec; 59(12):1333-9. PubMed ID: 18095482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chimaerins act downstream from neurotrophins in overcoming the inhibition of neurite outgrowth produced by myelin-associated glycoprotein.
    Mizuno T; Yamashita T; Tohyama M
    J Neurochem; 2004 Oct; 91(2):395-403. PubMed ID: 15447672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Axonal growth inhibitors and their receptors in spinal cord injury: from biology to clinical translation.
    Chambel SS; Cruz CD
    Neural Regen Res; 2023 Dec; 18(12):2573-2581. PubMed ID: 37449592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.